XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
WARRANTS
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Warrants [Abstract]    
WARRANTS [Text Block]

13. WARRANTS

The following summarizes the number of warrants outstanding as of March 31, 2024:

    Number of warrants    

Weighted average

exercise price

 
    Thousands        

Balance, December 31, 2023

2,384   $ 9.90  
Balance, March 31, 2024   2,384   $ 9.90  
 
Date of expiry  

Warrants

outstanding

   

Exercise

price

   

Grant date fair

value

   

Remaining life

in years

 
    Thousands                    
November 18, 2026   221   $ 75.00   $ 6,729     2.64  
November 18, 2027   23     66.00     1,055     3.64  
December 8, 2027   25     8.80     149     3.69  
September 21, 2028   691     2.50     712     4.48  
September 21, 2028   55     2.39     81     4.48  
March 21, 2029   1,369     2.50     1,120     4.98  
    2,384   $ 9.90   $ 9,846     4.58  

17. WARRANTS

On September 21, 2023, the Company issued 1,369,000 warrants issued as part of the September 2023 unit offering (Note 15). Each warrant permits the holder to purchase one common share of the Company through March 21, 2029 for $2.50. The issue date fair value of the warrants was estimated at $1.1 million using the Black Scholes option pricing model with the following assumptions: expected dividend yield of 0%; expected volatility of 100% based on comparable companies; risk-free interest rate of 4.3% and an expected life of 5.5 years. The resulting grant date fair value of each warrant was $0.82. Additionally, the Company amended the exercise price with respect to 66,245 and 624,995 warrants that (Note 15) that were previously issued in the November 2021 and December 2022 (described below) offerings, respectively, from $8.00 per share to $2.50 per share and recorded at $0.2 million gain on these warrant modifications.

Related to the September 2023 unit offering, 54,760 warrants were issued to the placement agent and recorded as issuance costs to share capital. Each warrant permits the holder to purchase one common share of the Company after the 181st day immediately following the date of issuance through September 21, 2028 for $2.39. The issue date fair value of the warrants was estimated at $0.1 million using the Black Scholes option pricing model with the following assumptions: expected dividend yield of 0%; expected volatility of 100% based on comparable companies; risk-free interest rate of 4.25% and an expected life of 5 years. The resulting grant date fair value of each warrant was $1.48.

On December 8, 2022, the Company issued 625,000 warrants issued as part of the December 2022 unit offering (Note 15). Each warrant permits the holder to purchase one common share of the Company through December 8, 2027 for $8.00. The issue date fair value of the warrants was estimated at $2.0 million using the Black Scholes option pricing model with the following assumptions: expected dividend yield of 0%; expected volatility of 100% based on comparable companies; risk-free interest rate of 3.0% and an expected life of 5 years. The resulting grant date fair value of each warrant was $3.25. Additionally, the Company amended the exercise price with respect to 66,250 warrants (Note 15) that were previously issued in the November 2021 offering from $75.00 per share to $8.00 per share.

Related to the December 2022 unit offering, 25,000 warrants were issued to the placement agent and recorded as issuance costs to share capital. Each warrant permits the holder to purchase one common share of the Company after the 180th day immediately following the date of issuance through December 8, 2027 for $8.00. The issue date fair value of the warrants was estimated at $0.1 million using the Black Scholes option pricing model with the following assumptions: expected dividend yield of 0%; expected volatility of 100% based on comparable companies; risk-free interest rate of 3.0% and an expected life of 5 years. The resulting grant date fair value of each warrant was $5.95.

The intrinsic value of warrants exercised for the year ended December 31, 2023 was less than $0.1 million ($0.5 million in 2022). The total fair value of warrants vested during the year ended December 31, 2023 was $1.3 million ($2.3 million in 2022).

For all warrants, common shares are newly issued from available authorized shares upon exercise of awards.

The following tables show warrants outstanding as at December 31, 2023:

    Number of warrants     Weighted average
exercise price
 
    Thousands        
Balance, December 31, 2021   438   $ 67.46  
Exercised   (24 )   9.83  
Cancelled   (103 )   60.00  
Issued   650     1.20  
Balance, December 31, 2022   961   $ 24.84  
Exercised   (1 )   8.00  
Cancelled   (691 )   8.00  
Issued   2,115     2.50  
Balance, December 31, 2023   2,384   $ 9.90  
 
Date of expiry   Warrants
outstanding
    Exercise
price
    Grant date fair
value
    Remaining life
in years
 
    Thousands                    
November 18, 2026   221   $ 75.00   $ 6,700     2.88  
November 18, 2027   23     66.00     1,055     3.88  
December 8, 2027   25     8.80     149     3.94  
September 21, 2028   691     2.50     522     4.73  
September 21, 2028   55     2.39     81     4.73  
March 21, 2029   1,369     2.50     1,339     5.22  
    2,384   $ 9.90   $ 9,846     4.83